Arzu Mulayim
Senior Medical Director, Mid Sized European Countries ACADIA Pharmaceuticals Inc.
Arzu Mulayim is a senior medical affairs leader at Acadia Pharmaceuticals, where she drives medical strategy across European markets in rare neurodevelopmental disorders. She specialises in aligning medical, evidence generation, and launch readiness to support successful therapy introduction in complex healthcare systems. Arzu brings extensive experience leading cross-regional medical teams across Europe, the Middle East, and emerging markets, with a strong focus on stakeholder collaboration, scientific engagement, and building strategies that translate clinical innovation into real-world patient impact.
Seminars
Tuesday 20th October 2026
Delivering Successful Early Access Across Europe: A Real-World Case Study on Programme Strategy & Execution
11:00 am
- Exploring ACADIA’s European early access journey: how different country pathways and programme types shaped execution, timelines, and operational complexity
- Sharing first-hand experience of managing multi-country programmes: where structured, centrally coordinated approaches increased cross-functional burden, resource demand, and delivery risk
- Demonstrating how pragmatic, country-level and ad-hoc access routes enabled faster patient access
- Lessons learned on aligning programme design with organisational readiness, resourcing, and anticipated regulatory uncertainty to ensure sustainable, successful delivery
